FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 45 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $920,000 | +9.0% | 229,983 | +32.1% | 0.00% | 0.0% |
| Q1 2019 | $844,000 | -14.2% | 174,050 | +12.9% | 0.00% | -33.3% |
| Q4 2018 | $984,000 | +45.8% | 154,190 | +87.4% | 0.00% | +50.0% |
| Q3 2018 | $675,000 | +16.8% | 82,268 | +48.6% | 0.00% | 0.0% |
| Q2 2018 | $578,000 | +4.3% | 55,348 | +20.7% | 0.00% | +100.0% |
| Q1 2018 | $554,000 | +5.1% | 45,848 | -13.2% | 0.00% | 0.0% |
| Q4 2017 | $527,000 | +15.6% | 52,848 | +28.5% | 0.00% | 0.0% |
| Q3 2017 | $456,000 | – | 41,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,056,000 | 0.85% |
| Southpoint Capital Advisors LP | 3,997,214 | $19,386,000 | 0.82% |
| 683 Capital Management, LLC | 971,351 | $4,711,000 | 0.43% |
| Avoro Capital Advisors LLC | 1,105,999 | $5,364,000 | 0.23% |
| Eventide Asset Management | 720,000 | $3,492,000 | 0.12% |
| Granahan Investment Management | 410,932 | $1,993,000 | 0.11% |
| Zebra Capital Management LLC | 17,568 | $85,000 | 0.04% |
| Hartford Financial Management Inc. | 12,300 | $60,000 | 0.02% |
| OXFORD ASSET MANAGEMENT LLP | 84,750 | $411,000 | 0.01% |
| Wealthspire Advisors, L.P. | 9,500 | $46,000 | 0.00% |